Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 887 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22221656_22221657del |
| Variant | c.1812del |
| Variant Start Position | 1812 |
| Location | Exon 18 |
| Amino Acid Change | p.Thr605Leufs*14 |
| ACMG Call | Pathogenic |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | - | Effect Type | Frameshift |
| Variant Type | Small deletion |
| PMID | 34806794 |
| Article Count | 1 |
| Times Observed | 6-10 |
| Clinical Phenotype | Reduced_TmP/GFR_(<LLN), Reduced Serum Phosphate, Gait abnormalities, Lower limb deformities |
| ACMG Categories | - |
| ACMG Explanations | - |
| Variant in Clinvar | No |
| ClinVar Classification | - |
| Categories In Literature | - |
| No Contrary Evidence Found | No |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | - |
| Literature Alleles | - |
| GnomAD Alleles | - |
| DBNSFP Alleles | - |
| Other Alleles | - |
| Note | nan |
| Warnings | - |